As filed with the Securities and Exchange Commission
on May 28, 2021
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM F-3
REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933
Bit Brother Limited
(Exact name of registrant as specified in its
charter)
|
British Virgin Islands
|
|
N/A
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification Number)
|
Room 910, Building 1, Huitong Building,
No.168, Hehua Road, Hehuayuan Street,
Furong District, Changsha City, Hunan Province
People’s Republic of China
+86 0731-85133570
(Address, including zip code, and telephone
number, including area code, of registrant’s principal executive offices)
Puglisi & Associates
850 Library Avenue
Suite 204
Newark, Delaware 19711
(Name, address, including zip code, and telephone
number, including area code, of agent for service)
Copies to:
Joan Wu, Esq.
Hunter Taubman Fischer & Li, LLC
800 Third Avenue, Suite 2800
New York, NY 10022
Tel: (212) 530-2208
Facsimile: (212) 202-6380
Approximate date of commencement of proposed sale
to the public: From time to time after the effective date of the registration statement.
If the only securities being registered on this
Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐
If any of the securities being registered on this
Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☒
If this Form is filed to register additional securities
for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed
pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. ☐
If this Form is a registration statement pursuant
to General Instruction I.C. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant
to Rule 462(e) under the Securities Act, check the following box. ☐
If this Form is a post-effective amendment to
a registration statement filed pursuant to General Instruction I.C. filed to register additional securities or additional classes of securities
pursuant to Rule 413(b) under the Securities Act, check the following box. ☐
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.
Emerging growth company ☐
If an emerging growth company that prepares its
financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards† provided pursuant to Section 7(a)(2)(B) of the Securities
Act. ☐
†The term “new or revised financial
accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification
after April 5, 2012.
CALCULATION OF REGISTRATION FEE
|
Title of Each Class of Securities to be Registered(1)
|
|
Amount
to be
Registered(2)
|
|
|
Proposed
Maximum
Aggregate Price
Per Share(3)
|
|
|
Proposed
Maximum
Aggregate
Offering Price
|
|
|
Amount of
Registration Fee(7)
|
|
|
Ordinary Shares, no par value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Shares, $0.0001 par value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Securities(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants(5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Units
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rights(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
$
|
200,000,000
|
|
|
$
|
21,820
|
|
|
(1)
|
Securities registered hereunder may be sold separately, together or as units with other securities registered hereunder.
|
|
(2)
|
We are registering an indeterminate number of Ordinary Shares, no par value (“Ordinary Shares”), preferred shares, warrants to purchase Ordinary Shares and/or preferred shares and/or units, each of which may be offered from time to time at prices to be determined at the time of any such offering. The aggregate offering price of these securities will not exceed $200,000,000. Any securities registered hereunder may be sold separately from, or together in the same offering with, other securities registered hereunder. In addition, pursuant to Rule 416 under the Securities Act, the shares being registered hereunder include such indeterminate number of Ordinary Shares and preferred shares as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.
|
|
(3)
|
The proposed maximum aggregate offering price per class of security will be determined from time to time by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder and is not specified as to each class of security in reliance on Rule 457(o) under the Securities Act of 1933.
|
|
(4)
|
There are also being registered hereunder an indeterminate principal amount or number of shares of debt securities, preferred shares or ordinary shares that may be issued upon conversion of, or in exchange for, debt securities or preferred shares registered hereunder or upon exercise of warrants registered hereunder, as the case may be.
|
|
(5)
|
Warrants may represent rights to purchase debt securities, Ordinary Shares, or other securities registered hereunder.
|
|
(6)
|
Consisting of some or all of the securities listed above, in any combination, including Ordinary Shares, preferred shares, warrants and units.
|
|
(7)
|
Calculated pursuant to Rule 457(o) under the Securities act of 1933, as amended.
|
The Registrant hereby amends
this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further
amendment that specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a)
of the Securities Act of 1933, as amended, or until this registration statement shall become effective on such date as the Securities
and Exchange Commission, acting pursuant to said Section 8(a), may determine.
The information in
this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the
Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an
offer to buy these securities in any state where the offer or sale is not permitted.
SUBJECT TO COMPLETION,
DATED MAY 28, 2021
PROSPECTUS
Bit Brother Limited
$200,000,000
Ordinary Shares, Preferred Shares, Debt Securities
Warrants, Units and Rights
We may, from time to time
in one or more offerings, offer and sell up to $200,000,000 in the aggregate of Ordinary Shares, preferred shares, warrants to purchase
Ordinary Shares or preferred shares, debt securities, rights or any combination of the foregoing, either individually or as units comprised
of one or more of the other securities. The prospectus supplement for each offering of securities will describe in detail the plan of
distribution for that offering. For general information about the distribution of securities offered, please see “Plan of Distribution”
in this prospectus.
This prospectus provides a
general description of the securities we may offer. We will provide the specific terms of the securities offered in one or more supplements
to this prospectus. We may also authorize one or more free writing prospectuses to be provided to you in connection with these offerings.
The prospectus supplement and any related free writing prospectus may add, update or change information contained in this prospectus.
You should read carefully this prospectus, the applicable prospectus supplement and any related free writing prospectus, as well as the
documents incorporated or deemed to be incorporated by reference, before you invest in any of our securities. This prospectus
may not be used to offer or sell any securities unless accompanied by the applicable prospectus supplement.
Pursuant to General Instruction
I.B.5. of Form F-3, in no event will we sell the securities covered hereby in a public primary offering with a value exceeding more than
one-third of the aggregate market value of our Ordinary Shares in any 12-month period so long as the aggregate market value of our outstanding
Ordinary Shares held by non-affiliates remains below $75,000,000. The aggregate market value of our outstanding voting and non-voting
common equity held by non-affiliates is approximately $94,561,483 based on the closing price of $4.64 per ordinary share on April 27,
2021 and 20,379,630 ordinary shares held by non-affiliates. During the 12 calendar months prior to and including the date of this prospectus,
we have not offered or sold any securities pursuant to General Instruction I.B.5 of Form F-3.
Our Ordinary Shares are listed
on the Nasdaq Capital Market under the symbol “ZCMD.” The applicable prospectus supplement will contain information, where
applicable, as to other listings, if any, on the Nasdaq Capital Market or other securities exchange of the securities covered by the prospectus
supplement.
Investing in our
securities involves a high degree of risk. See “Risk Factors” on page 4 of this prospectus and in the documents
incorporated by reference in this prospectus, as updated in the applicable prospectus supplement, any related free writing
prospectus and other future filings we make with the Securities and Exchange Commission that are incorporated by reference into this
prospectus, for a discussion of the factors you should consider carefully before deciding to purchase our securities.
We may sell these securities
directly to investors, through agents designated from time to time or to or through underwriters or dealers. For additional information
on the methods of sale, you should refer to the section entitled “Plan of Distribution” in this prospectus. If any underwriters
are involved in the sale of any securities with respect to which this prospectus is being delivered, the names of such underwriters and
any applicable commissions or discounts will be set forth in a prospectus supplement. The price to the public of such securities and the
net proceeds we expect to receive from such sale will also be set forth in a prospectus supplement.
Neither the Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus
is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus is May 28, 2021.
TABLE
OF CONTENTS
ABOUT THIS PROSPECTUS
This prospectus is part of
a registration statement that we filed with the Securities and Exchange Commission, or the SEC, under the Securities Act of 1933, as amended,
or the Securities Act, using a “shelf” registration process. Under this shelf registration process, we may from time to time
sell Ordinary Shares, preferred shares, warrants to purchase Ordinary Shares or preferred shares, debt securities or any combination of
the foregoing, either individually or as units comprised of one or more of the other securities, in one or more offerings up to a total
dollar amount of $200,000,000. We have provided to you in this prospectus a general description of the securities we may offer. Each time
we sell securities under this shelf registration, we will, to the extent required by law, provide a prospectus supplement that will contain
specific information about the terms of that offering. We may also authorize one or more free writing prospectuses to be provided to you
that may contain material information relating to these offerings. The prospectus supplement and any related free writing prospectus that
we may authorize to be provided to you may also add, update or change information contained in this prospectus or in any documents that
we have incorporated by reference into this prospectus. To the extent there is a conflict between the information contained in this prospectus
and the prospectus supplement or any related free writing prospectus, you should rely on the information in the prospectus supplement
or the related free writing prospectus; provided that if any statement in one of these documents is inconsistent with a statement in another
document having a later date – for example, a document filed after the date of this prospectus and incorporated by reference into
this prospectus or any prospectus supplement or any related free writing prospectus – the statement in the document having the later
date modifies or supersedes the earlier statement.
We have not authorized any
dealer, agent or other person to give any information or to make any representation other than those contained or incorporated by reference
in this prospectus and any accompanying prospectus supplement, or any related free writing prospectus that we may authorize to be provided
to you. You must not rely upon any information or representation not contained or incorporated by reference in this prospectus or an accompanying
prospectus supplement, or any related free writing prospectus that we may authorize to be provided to you. This prospectus and the accompanying
prospectus supplement, if any, do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the
registered securities to which they relate, nor do this prospectus and the accompanying prospectus supplement constitute an offer to sell
or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation
in such jurisdiction. You should not assume that the information contained in this prospectus, any applicable prospectus supplement or
any related free writing prospectus is accurate on any date subsequent to the date set forth on the front of the document or that any
information we have incorporated by reference is correct on any date subsequent to the date of the document incorporated by reference
(as our business, financial condition, results of operations and prospects may have changed since that date), even though this prospectus,
any applicable prospectus supplement or any related free writing prospectus is delivered or securities are sold on a later date.
As permitted by SEC rules
and regulations, the registration statement of which this prospectus forms a part includes additional information not contained in this
prospectus. You may read the registration statement and the other reports we file with the SEC at its website or at its offices described
below under “Where You Can Find More Information.”
Unless the context otherwise
requires, all references in this prospectus to “Bit Brother,” “we,” “us,” “our,” “the
Company,” “the “Registrant” or similar words refer to Bit Brother Limited, together with our subsidiaries.
NOTE REGARDING FORWARD-LOOKING STATEMENTS
This prospectus and our SEC
filings that are incorporated by reference into this prospectus contain or incorporate by reference forward-looking statements within
the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. All statements other than statements of historical
fact are “forward-looking statements,” including any projections of earnings, revenue or other financial items, any statements
of the plans, strategies and objectives of management for future operations, any statements concerning proposed new projects or other
developments, any statements regarding future economic conditions or performance, any statements of management’s beliefs, goals,
strategies, intentions and objectives, and any statements of assumptions underlying any of the foregoing. The words “believe,”
“anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “could,”
“should,” “potential,” “likely,” “projects,” “continue,” “will,”
and “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking
statements contain these identifying words. Forward-looking statements reflect our current views with respect to future events, are based
on assumptions and are subject to risks and uncertainties. We cannot guarantee that we actually will achieve the plans, intentions or
expectations expressed in our forward-looking statements and you should not place undue reliance on these statements. There are a number
of important factors that could cause our actual results to differ materially from those indicated or implied by forward-looking statements.
These important factors include those discussed under the heading “Risk Factors” contained or incorporated by reference in
this prospectus and in the applicable prospectus supplement and any free writing prospectus we may authorize for use in connection with
a specific offering. These factors and the other cautionary statements made in this prospectus should be read as being applicable to all
related forward-looking statements whenever they appear in this prospectus. Except as required by law, we undertake no obligation to update
publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
OUR BUSINESS
Business Overview
Bit Brother Limited (formerly
known as Urban Tea, Inc., Delta Technology Holdings Ltd, and prior to that as CIS Acquisition Ltd.) was incorporated in the British Virgin
Islands as a company with limited liability on November 28, 2011. We have become a retailer and distributor of specialty tea products
in China (also referred to as “PRC”) since November 2018, and have fully completed the disposition of our fine and specialty
chemical manufacturing business in April 2019. Our business currently consists of the distribution and retail of specialty tea products.
We have recently decided to start operations in the business of blockchain technology and cyptocurrency mining. We anticipate to utilize
a new subsidiary to conduct research and development of blockchain-based software and applications and the commercialization of such application
as well as cryptocurrency mining.
Recent Developments
On February 17, 2021, the
Company announced its planned entry into the blockchain and cryptocurrency mining business and also appointed Dr. Yunfei Song as an independent
director of the Company board of directors to lead and support the Company’s critical strategic expansion.
Dr. Yunfei Song is a scientist
at the Chinese Academy of Sciences. His prominent strategy model achievement includes fields of blockchain technology application, artificial
intelligence, exchange quantification, and brick moving robots. Additionally, Dr. Song has extensive experience in cryptocurrency mining
and digital asset management. He will serve as an independent director and provide guidance to the Company's blockchain development strategy.
On March 26, 2021, the Company
entered into certain securities purchase agreement with certain “non-U.S. Persons” as defined in Regulation S of the Securities
Act pursuant to which the Company agreed to sell an aggregate of 3,797,488 units (the “Units”), each Unit consisting of one
ordinary share of the Company, no par value (“Share”) and a warrant to purchase three Shares (“Warrant”) with
an initial exercise price of $4.65 per Share, at a price of $3.72 per Unit, for an aggregate purchase price of approximately $14.1 million
(the “March 2021 PIPE”). The March 2021 PIPE closed on April 20, 2021 when all the closing conditions were satisfied. The
net proceeds to the Company from the March 2021 PIPE were approximately $14.1 million and shall be used by the Company for the planned
blockchain and cryptocurrency mining operations and for working capital and general corporate purposes.
On May 20, 2021, we received
the stamped Certificate of Change of Name from the British Virgin Islands Registrar of Corporate Affairs dated May 20, 2021 pursuant to
which the Company’s name has been changed from “Urban Tea, Inc.” to “Bit Brother Limited.”
In connection with Name Change, the Company anticipates to effectuate
a change of its ticker symbol and is currently in the process of reserving a new symbol with Nasdaq as well as applying for a new CUSIP
number for the new name and ticker symbol.
Corporate Information
Our principal executive offices
are located at Room 910, Building 1, Huitong Building, No.168, Hehua Road, Hehuayuan Street, Furong District, Changsha City, Hunan Province,
People’s Republic of China. We do not own any real property or have any land use rights. Our telephone number at that address is
+86 0731-85133570. Our company website is www.h-n-myt.com. Our NASDAQ symbol is MYT, and we make our SEC filings available on the Investor
Relations page of our website, www.h-n-myt.com. Information contained on our website is not part of this prospectus. Our agent for service
in the United States is VStock Transfer, LLC, the current transfer agent of the Company, with a mailing address of 18 Lafayette Place
Woodmere, NY 11598.
RISK FACTORS
Investing in our securities
involves a high degree of risk. You should carefully consider the risk factors set forth under “Risk Factors” described in
our most recent annual report on Form 20-F, filed on April 30, 2021, as supplemented and updated by subsequent current reports on
Form 6-K that we have filed with the SEC, together with all other information contained or incorporated by reference in this prospectus
and any applicable prospectus supplement and in any related free writing prospectus in connection with a specific offering, before making
an investment decision. Each of the risk factors could materially and adversely affect our business, operating results, financial condition
and prospects, as well as the value of an investment in our securities, and the occurrence of any of these risks might cause you to lose
all or part of your investment.
Risks Relating to the Planned Blockchain and
Cryptocurrency Mining Business
Investment in our new line of business
could present risks not originally contemplated.
The
Company plans on investing in its planned expansion into the blockchain and cryptocurrency mining business. New ventures are inherently
risky and may not be successful. In evaluating such endeavors, we are required to make difficult judgments regarding the value of business
strategies, opportunities, technologies and other assets, and the risks and cost of potential liabilities. Furthermore, these investments
involve certain other risks and uncertainties, including the risks involved with entering new competitive categories or regions, the difficulty
in integrating the new business, and the challenges in achieving strategic objectives and other benefits expected from our investment.
If we are unable to successfully execute
our planned blockchain and cryptocurrency mining business plan, it would affect our financial and business condition and results of operations.
Our previously announced growth
strategy included the expansion of our operations to include a blockchain and cryptocurrency mining business. There are various risks
related to these efforts, including the risk that these efforts may not provide the expected benefits in our anticipated time frame, if
at all, and may prove costlier than expected; and the risk of adverse effects to our business, results of operations and liquidity if
past and future undertakings, and the associated changes to our business, do not prove to be cost effective or do not result in the cost
savings and other benefits at the levels that we anticipate. Our intentions and expectations with regard to the execution of our business
plan, and the timing of any related initiatives, are subject to change at any time based on management’s subjective evaluation of
our overall business needs. If we are unable to successfully execute our business plan, whether due to failure to realize the anticipated
benefits from our business initiatives in the anticipated time frame or otherwise, we may be unable to achieve our financial targets.
Cryptocurrency mining relies on a steady
and inexpensive power supply for operating mining farms and running mining hardware. Failure to access a large quantity of power at reasonable
costs could significantly increase our operating expenses and adversely affect our demand for our mining machines.
Cryptocurrency mining consumes
a significant amount of energy power to process the computations and cool down the mining hardware. Therefore, a steady and inexpensive
power supply is critical to cryptocurrency mining. There can be no assurance that the operations of our planned cryptocurrency mining
business will not be affected by power shortages or an increase in energy prices in the future. In addition, as we intend to establish
and operate mining machines and engage in key mainstream cryptocurrencies mining activities, such as Bitcoin, in the near future, any
increase in energy prices or a shortage in power supply in the area of our mining machines may be located will increase our potential
mining costs and reduce the expected economic returns from our mining operation significantly.
In particular, the power supply
could be disrupted by natural disasters, such as floods, mudslides and earthquakes, or other similar events beyond our control. Further,
we may experience power shortages due to seasonal variations in the supply of certain types of power such as hydroelectricity. Power shortages,
power outages or increased power prices could adversely affect our mining businesses. Under such circumstances, our business, results
of operations and financial condition could be materially and adversely affected.
Shortages in, or rises in the prices of
mining machines may adversely affect our business
Given the long production
period to manufacture and assemble mining machines, there is no assurance that we can acquire enough mining machines for our planned cryptocurrency
mining. We may rely on third parties to supply mining machines to us, and shortages of mining machines or any delay in delivery of our
orders could seriously interrupt our operations. The scale of our cryptocurrency mining capacity depends on obtaining adequate mining
machines on a timely basis and at competitive prices. Shortages of mining machines could result in reduced mining capacity, as well as
an increase in operation costs, which could materially delay the completion of our mining capacity and commencement of our mining. As
a result, our business, results of operations and reputation could be materially and adversely affected.
We may not be able to develop our cryptocurrency
mining capacity because we may fail to anticipate or adapt to technology innovations in a timely manner, or at all.
The cryptocurrencies mining
industry is experiencing rapid technological changes. Failure to anticipate technology innovations or adapt to such innovations in a timely
manner, or at all, may result in our research becoming obsolete at sudden and unpredictable intervals and, accordingly, we may not successfully
develop our mining capacity at all. To establish our cryptocurrency mining capacity, we will invest heavily in technology research and
development. The process of research and developing new technologies in cryptocurrency is inherently complex and involves significant
uncertainties. There are a number of risks, including the following:
|
|
●
|
our
research and development efforts may fail in resulting in the development or commercialization of new technologies or ideas in blockchain
or cryptocurrency;
|
|
|
●
|
our
research and development efforts may fail to translate new product plans into commercially feasible products;
|
|
|
●
|
our
new technologies or new products may not be well received by the markets;
|
|
|
●
|
we
may not have adequate funding and resources necessary for continual investments in research and development;
|
|
|
●
|
even
assuming our technologies and products become marketable or profitable, they may become obsolete due to rapid advancements in technology
and changes in the mainstream markets; and
|
|
|
●
|
our
newly developed technologies may not be protected as proprietary intellectual property rights.
|
Our research and development
efforts may not yield the expected results, or may prove to be futile due to the lack of market demand. Further, any failure to anticipate
the next-generation technology roadmap or changes in the mainstream markets or to timely develop new or enhanced technologies in response
could result in loss of our business.
Adverse changes in the regulatory environment
in the PRC market could have a material adverse impact on our planned cryptocurrency related business.
Our planned cryptocurrency
mining will be in China. Our cryptocurrency related products business could therefore be significantly affected by, among other things,
the regulatory developments in the PRC. Governmental authorities are likely to continue to issue new laws, rules and regulations governing
the cryptocurrency industry that we plan to enter and enhance enforcement of existing laws, rules and regulations. For example, Xinjiang,
an autonomous region in northwest China, warned local Bitcoin mining enterprises that were operating illegally to close their operations
before August 30, 2018 and the People’s Bank of China, or the PBOC, imposed a ban in September 2017 prohibiting financial institutions
from engaging in initial coin offering transactions. Some jurisdictions, including the PRC, restrict various uses of cryptocurrencies,
including the use of cryptocurrencies as a medium of exchange, the conversion between cryptocurrencies and fiat currencies or between
cryptocurrencies, the provision of trading and other services related to cryptocurrencies by financial institutions and payment institutions,
and initial coin offerings and other means of capital raising based on cryptocurrencies. In addition, cryptocurrencies may be used by
market participants for black market transactions, to conduct fraud, money laundering and terrorism-funding, tax evasion, economic sanction
evasion or other illegal activities. As a result, governments may seek to regulate, restrict, control or ban the mining, use, holding
and transferring of cryptocurrencies.
With advances in technology,
cryptocurrencies are likely to undergo significant changes in the future. It remains uncertain whether cryptocurrencies will be able to
cope with, or benefit from, those changes. In addition, as cryptocurrency mining employs sophisticated and high computing power devices
that need to consume large amounts of electricity to operate, future developments in the regulation of energy consumption, including possible
restrictions on energy usage in the jurisdictions where we intend to deploy our mining capacities, may also affect the development of
our business plan. There has been negative public reaction to surrounding the environmental impact of Bitcoin mining, particularly the
large consumption of electricity, and governments of various jurisdictions have responded.
Further, relevant restrictions
from existing and future regulations on mining, holding, using, or transferring of cryptocurrencies may adversely affect our future business
operations and results of operations. For example, although mining activities have not been explicitly prohibited by the PRC government,
any further order of the PRC government to limit cryptocurrency mining may result in a crackdown on the cryptocurrency
market and adversely affect our cryptocurrency-related business plans. If any jurisdictions impose limitations on the mining, use, holding
or transferring of cryptocurrencies or any cryptocurrency-related activity, our business prospects, operations and financial results may
be negatively impacted.
In addition, if cryptocurrencies
or the mining of cryptocurrencies are regarded as securities by various governmental authorities, our planned cryptocurrency mining is
likely to be deemed as issuance of cryptocurrencies to investors for financing purpose and thus prohibited under the PRC laws. Any such
regulations, if implemented, will cause us to incur additional compliance costs and have a material adverse effect on our future business
operations.
We may face intense industry competition.
Cryptocurrency mining, security,
and insurance is in a highly competitive environment. Our competitors include companies that may have a longer history, larger market
share, greater brand recognition, greater financial resources in research or other competitive advantages. We anticipate that competition
will increase as cryptocurrencies gain greater acceptance and more players join the market of cryptocurrency mining and mining farm operations.
Strong competition in the
market may require us to increase our marketing expenses and sales expenses, if any, or otherwise invest greater resources to gain market
shares and expand our mining capacities as needed to adequately compete. Such efforts may negatively impact our profitability. If we are
unable to effectively meet our business plans in the competitive landscape, our business, financial conditions and results of operations
may be adversely affected.
Because cryptocurrencies may be determined
to be investment securities, we may inadvertently violate the Investment Company Act and incur large losses as a result and potentially
be required to register as an investment company or terminate operations and we may incur third party liabilities.
In recent years, the SEC has
ruled that the two most valuable cryptocurrencies—Bitcoin and Ethereum—are not securities. We therefore believe that we will
not be deemed to be engaged in the business of investing, reinvesting, or trading in securities, and we shall not hold ourselves out as
being engaged in those activities. However, under the Investment Company Act a company may be deemed an investment company under section
3(a)(1)(C) thereof if the value of its investment securities is more than 40% of its total assets (exclusive of government securities
and cash items) on an unconsolidated basis.
As a result of our planned
investments and our mining activities, including investments in which we do not have a controlling interest, the investment securities
we hold could exceed 40% of our total assets, exclusive of cash items and, accordingly, we could determine that we have become an inadvertent
investment company. The bitcoins we own, acquire or mine may be deemed an investment security by the SEC, although we do not believe any
of the cryptocurrencies we own, acquire or mine are securities. An inadvertent investment company can avoid being classified as an investment
company if it can rely on one of the exclusions under the Investment Company Act. One such exclusion, Rule 3a-2 under the Investment Company
Act, allows an inadvertent investment company a grace period of one year from the earlier of (a) the date on which an issuer owns securities
and/or cash having a value exceeding 50% of the issuer’s total assets on either a consolidated or unconsolidated basis and (b) the
date on which an issuer owns or proposes to acquire investment securities having a value exceeding 40% of the value of such issuer’s
total assets (exclusive of government securities and cash items) on an unconsolidated basis. We may take actions to cause the investment
securities held by us to be less than 40% of our total assets, which may include acquiring assets with our cash and bitcoin on hand or
liquidating our investment securities or bitcoin or seeking a no-action letter from the SEC if we are unable to acquire sufficient assets
or liquidate sufficient investment securities in a timely manner.
As the Rule 3a-2 exception
is available to a company no more than once every three years, and assuming no other exclusion were available to us, we would have to
keep within the 40% limit for at least three years after we cease being an inadvertent investment company. This may limit our ability
to make certain investments or enter into joint ventures that could otherwise have a positive impact on our earnings. In any event, we
do not intend to become an investment company engaged in the business of investing and trading securities.
Classification as an investment
company under the Investment Company Act requires registration with the SEC. If an investment company fails to register, it would have
to stop doing almost all business, and its contracts would become voidable. Registration is time consuming and restrictive and would require
a restructuring of our operations, and we would be very constrained in the kind of business we could do as a registered investment company.
Further, we would become subject to substantial regulation concerning management, operations, transactions with affiliated persons and
portfolio composition, and would need to file reports under the Investment Company Act regime. The cost of such compliance would result
in the Company incurring substantial additional expenses, and the failure to register if required would have a materially adverse impact
to conduct our operations.
Risks Relating to the Current Pandemic
Our business, results of operations and
financial condition may be adversely affected by global public health epidemics, including the strain of coronavirus known as COVID-19.
In December 2019, a novel
strain of coronavirus causing respiratory illness, or COVID-19, has surfaced in Wuhan, China, spreading at a fast rate in January and
February of 2020, and confirmed cases were also reported in other parts of the world. In reaction to this outbreak, an increasing number
of countries imposed travel suspensions to and from China following the World Health Organization’s “public health emergency
of international concern” (PHEIC) announcement on January 30, 2020. Since this outbreak, business activities in China and many other
countries including U.S. have been disrupted by a series of emergency quarantine measures taken by the government.
As a result, our operations
in China and the U.S. have been materially affected. Our stores in China were temporarily closed until early March and have been gradually
opening since then. As a result, the Company expects a lower amount of revenue and net income from February to April 2020 due to the downtime.
In addition, the renovation of our new store in New York City which was expected to open in early 2020 was delayed due to COVID-19 related
restrictions in the U.S. Accordingly, our operation and business have been and will continue to be adversely affected as the results of
the wide-spread pandemic. Management may have to adjust or change our business plan in response to the prolonged pandemic and change of
social behavior.
The extent to which COVID-19
negatively impacts our business is highly uncertain and cannot be accurately predicted. We believe that the coronavirus outbreak and the
measures taken to control it may have a significant negative impact on not only our business, but economic activities globally. The magnitude
of this negative effect on the continuity of our business operation in China and U.S. remains uncertain. These uncertainties impede our
ability to conduct our daily operations and could materially and adversely affect our business, financial condition and results of operations,
and as a result affect our share price and create more volatility.
Techniques employed by short sellers may
drive down the market price of our ordinary shares.
Short selling is the practice
of selling securities that the seller does not own but rather has borrowed from a third party with the intention of buying identical securities
back at a later date to return to the lender. The short seller hopes to profit from a decline in the value of the securities between the
sale of the borrowed securities and the purchase of the replacement shares, as the short seller expects to pay less in that purchase than
it received in the sale. As it is in the short seller’s interest for the price of the security to decline, many short sellers publish,
or arrange for the publication of, negative opinions regarding the relevant issuer and its business prospects in order to create negative
market momentum and generate profits for themselves after selling a security short. These short attacks have, in the past, led to selling
of shares in the market.
Public companies listed in
the United States that have a substantial majority of their operations in China have been the subject of short selling. Much of the scrutiny
and negative publicity has centered on allegations of a lack of effective internal control over financial reporting resulting in financial
and accounting irregularities and mistakes, inadequate corporate governance policies or a lack of adherence thereto and, in many cases,
allegations of fraud. As a result, many of these companies are now conducting internal and external investigations into the allegations
and, in the interim, are subject to shareholder lawsuits and/or SEC enforcement actions.
We may in the future be, the
subject of unfavorable allegations made by short sellers. Any such allegations may be followed by periods of instability in the market
price of our ordinary shares and negative publicity. If and when we become the subject of any unfavorable allegations, whether such allegations
are proven to be true or untrue, we could have to expend a significant amount of resources to investigate such allegations and/or defend
ourselves. While we would strongly defend against any such short seller attacks, we may be constrained in the manner in which we can proceed
against the relevant short seller by principles of freedom of speech, applicable federal or state law or issues of commercial confidentiality.
Such a situation could be costly and time-consuming and could distract our management from growing our business. Even if such allegations
are ultimately proven to be groundless, allegations against us could severely impact our business operations and shareholder’s equity,
and the value of any investment in our ordinary shares could be greatly reduced or rendered worthless.
Risk Relating to Our Ordinary Shares
If we fail to comply with the continued
listing requirements of NASDAQ, we would face possible delisting, which would result in a limited public market for our shares and make
obtaining future debt or equity financing more difficult for us.
On July 10, 2019, the Company
received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”) notifying
the Company that the minimum bid price per share for its common shares has been below $1.00 for a period of 30 consecutive business days
and the Company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) (the “Deficiency”).
Under the Nasdaq Listing Rules,
the Company had until January 6, 2020 to regain compliance, and may be eligible for an extension of an additional 180 calendar days, provided
that the Company meets the continued listing requirement for market value of publicly held shares and all other initial listing standards
for Nasdaq except for Nasdaq Listing Rule 5550(a)(2), and provide a written notice of its intention to cure this deficiency during the
second compliance period, by effecting a reverse stock split, if necessary.
On December 3, 2019, the Company
provided written notice to Nasdaq requesting for an extension through July 3, 2020 to demonstrate compliance with the Deficiency during
the second compliance period.
On April 20, 2020, the Company
received a notification letter from Nasdaq notifying the Company that Nasdaq has determined to toll the compliance periods for bid price
requirements (the “Price-based Requirements”) through June 30, 2020. Accordingly, since the Company had 79 calendar days remaining
in its bid price compliance period as of April 16, 2020, it will, upon reinstatement of the Price-based Requirements, still have 79 calendar
days from July 1, 2020, or until September 17, 2020, to regain compliance.
On September 11, 2020, the
Company received a written notification from the Nasdaq Stock Market Listing Qualifications Staff, indicating that the Company has regained
compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2)
based on the Company’s closing bid price being $1.00 per share or greater for 10 consecutive business days from August 27 to September
10, 2020.
If the Company fails to maintain
compliance with other listing rules in the future, we could be subject to suspension and delisting proceedings. If our securities lose
their status on The NASDAQ Capital Market, our securities would likely trade in the over-the-counter market. If our securities were to
trade on the over-the-counter market, selling our securities could be more difficult because smaller quantities of securities would likely
be bought and sold, transactions could be delayed, and security analysts’ coverage of us may be reduced. In addition, in the event
our securities are delisted, broker-dealers have certain regulatory burdens imposed upon them, which may discourage broker-dealers from
effecting transactions in our securities, further limiting the liquidity of our securities. These factors could result in lower prices
and larger spreads in the bid and ask prices for our securities. Such delisting from The NASDAQ Capital Market and continued or further
declines in our share price could also greatly impair our ability to raise additional necessary capital through equity or debt financing,
and could significantly increase the ownership dilution to shareholders caused by our issuing equity in financing or other transactions.
USE OF PROCEEDS
Except as described in any
prospectus supplement and any free writing prospectus in connection with a specific offering, we currently intend to use the net proceeds
from the sale of the securities offered under this prospectus to fund the development and commercialization of our projects and the growth
of our business, primarily working capital, and for general corporate purposes. We may also use a portion of the net proceeds to acquire
or invest in technologies, products and/or businesses that we believe will enhance the value of our Company, although we have no current
commitments or agreements with respect to any such transactions as of the date of this prospectus. We have not determined the amount of
net proceeds to be used specifically for the foregoing purposes. As a result, our management will have broad discretion in the allocation
of the net proceeds and investors will be relying on the judgment of our management regarding the application of the proceeds of any sale
of the securities. If a material part of the net proceeds is to be used to repay indebtedness, we will set forth the interest rate and
maturity of such indebtedness in a prospectus supplement. Pending use of the net proceeds will be deposited in interest bearing bank accounts.
DILUTION
If required, we will set forth
in a prospectus supplement the following information regarding any material dilution of the equity interests of investors purchasing securities
in an offering under this prospectus:
|
|
●
|
the
net tangible book value per share of our equity securities before and after the offering;
|
|
|
●
|
the
amount of the increase in such net tangible book value per share attributable to the cash payments made by purchasers in the offering;
and
|
|
|
●
|
the
amount of the immediate dilution from the public offering price which will be absorbed by such purchasers.
|
DESCRIPTION OF SHARE CAPITAL
The following description
of our share capital which solely consists of ordinary shares and preferred shares, together with any additional information we include
in any applicable prospectus supplement or any related free writing prospectus, summarizes the material terms and provisions of our ordinary
shares and the preferred shares that we may offer under this prospectus. While the terms we have summarized below will apply generally
to any future ordinary shares or preferred shares that we may offer, we will describe the particular terms of any class or series of these
securities in more detail in the applicable prospectus supplement. For the complete terms of our ordinary shares and preferred shares,
please refer to our Memorandum and Articles of Association, that is incorporated by reference into the registration statement of which
this prospectus is a part or may be incorporated by reference in this prospectus or any applicable prospectus supplement. The terms of
these securities may also be affected by British Virgin Islands law. The summary below and that contained in any applicable prospectus
supplement or any related free writing prospectus are qualified in their entirety by reference to our Memorandum and Articles of Association,
as in effect at the time of any offering of securities under this prospectus. For information on how to obtain copies of our Memorandum
and Articles of Association, see “Where You Can Find More Information.”
We, directly or through agents,
dealers or underwriters designated from time to time, may offer, issue and sell, together or separately, up to $200,000,000 in the aggregate
of:
|
|
●
|
secured
or unsecured debt securities consisting of notes, debentures or other evidences of indebtedness which may be senior debt securities,
senior subordinated debt securities or subordinated debt securities, each of which may be convertible into equity securities;
|
|
|
●
|
warrants
to purchase our securities;
|
|
|
●
|
rights
to purchase our securities; or
|
|
|
●
|
units
comprised of, or other combinations of, the foregoing securities.
|
We may issue the debt securities
as exchangeable for or convertible into Ordinary Shares, preferred shares or other securities. The preferred shares may also be exchangeable
for and/or convertible into Ordinary Shares, another series of preferred shares or other securities. The debt securities, the preferred
shares, the Ordinary Shares and the warrants are collectively referred to in this prospectus as the “securities.” When a particular
series of securities is offered, a supplement to this prospectus will be delivered with this prospectus, which will set forth the terms
of the offering and sale of the offered securities.
Description of Ordinary Shares and Preferred Shares
The following description
of our ordinary shares and preferred shares, together with any additional information we include in any applicable prospectus supplement
or any related free writing prospectus, summarizes the material terms and provisions of our ordinary shares and the preferred shares that
we may offer under this prospectus. While the terms we have summarized below will apply generally to any future ordinary shares or preferred
shares that we may offer, we will describe the particular terms of any class or series of these securities in more detail in the applicable
prospectus supplement. For the complete terms of our ordinary shares and preferred shares, please refer to our M&A that is incorporated
by reference into the registration statement of which this prospectus is a part or may be incorporated by reference in this prospectus
or any applicable prospectus supplement. The terms of these securities may also be affected by British Virgin Islands law. The summary
below and that contained in any applicable prospectus supplement or any related free writing prospectus are qualified in their entirety
by reference to our Memorandum and Articles of Association, as in effect at the time of any offering of securities under this prospectus.
For information on how to obtain copies of our M&A, see “Where You Can Find More Information.”
Our authorized capital stock
consists of an unlimited number of shares divided into: (a) an unlimited number of ordinary shares with no par value; and (b) 5,000,000
preferred shares, par value $0.0001 per share. As of May 28, 2021, 20,384,630 ordinary shares were outstanding. Each share, regardless
if it is part of a class of ordinary shares, has the right to one vote at a meeting of shareholders or on any resolution of shareholders,
the right to an equal share in any dividend paid by us, and the right to an equal share in the distribution of surplus assets. We may
by a resolution of the Board of Directors redeem our shares for such consideration as the Board of Directors determines.
If, at any time, our authorized
number of shares is divided into different classes of shares, the rights attached to any class (unless otherwise provided by the terms
of issue of the shares of that class) may, whether or not we are being wound-up, be varied with the consent in writing of the holders
of three-fourths of the issued shares of that class or with the sanction of a resolution passed by a majority of the votes cast at a separate
meeting of the holders of the shares of the class at which meeting the necessary quorum shall be two persons at least holding or representing
by proxy one-third of the issued shares of the class.
At least 10 days’ (exclusive
of the date that notice is given and the date on which event for which notice is given is to take effect) notice of a meeting shall be
given to each shareholder entitled to attend and vote thereat, stating the date, place, and time at which the meeting is to be held, and
if different, the record date for determining shareholders entitled to attend and vote at the meeting, and the general nature of the business
to be conducted at the meeting. A meeting shall, notwithstanding the fact that it is called on shorter notice than otherwise required,
be deemed to have been properly called if it is attended, or such notice is waived, by 90% of the shareholders entitled to attend and
vote thereat. The inadvertent failure to give notice of a meeting to, or the non-receipt of a notice of a meeting by, any person entitled
to receive notice shall not invalidate the proceedings at that meeting.
There are no limitations on
the rights to own our securities, or limitations on the rights of non-resident or foreign shareholders to hold or exercise voting rights
on our securities, contained in our Amended and Restated Memorandum and Articles of Association (or under British Virgin Islands law).
Description of Warrants
General
We may issue warrants for
the purchase of ordinary shares or preferred shares. Warrants may be offered independently or together with ordinary shares or preferred
shares offered by any prospectus supplement and may be attached to or separate from those securities. While the terms we have summarized
below will apply generally to any warrants that we may offer under this prospectus, we will describe in particular the terms of any series
of warrants that we may offer in more detail in the applicable prospectus supplement and any applicable free writing prospectus. The terms
of any warrants offered under a prospectus supplement may differ from the terms described below.
We will file as an exhibit
to the registration statement of which this prospectus is a part, or will incorporate by reference from another report that we file with
the SEC, the form of warrant and/or warrant agreement, which may include a form of warrant certificate, as applicable, that describes
the terms of the particular series of warrants we may offer before the issuance of the related series of warrants. We may issue the warrants
under a warrant agreement that we will enter into with a warrant agent to be selected by us. The warrant agent will act solely as our
agent in connection with the warrants and will not assume any obligation or relationship of agency or trust for or with any registered
holders of warrants or beneficial owners of warrants. The following summary of material provisions of the warrants and warrant agreements
is subject to, and qualified in its entirety by reference to, all the provisions of the form of warrant and/or warrant agreement and warrant
certificate applicable to a particular series of warrants. We urge you to read the applicable prospectus supplement and any related free
writing prospectus, as well as the complete form of warrant and/or the warrant agreement and warrant certificate, as applicable, that
contain the terms of the warrants.
The particular terms of any
issue of warrants will be described in the prospectus supplement relating to the issue. Those terms may include:
|
|
●
|
the
title of such warrants;
|
|
|
●
|
the
aggregate number of such warrants;
|
|
|
●
|
the
price or prices at which such warrants will be issued;
|
|
|
●
|
the
currency or currencies (including composite currencies) in which the price of such warrants may be payable;
|
|
|
●
|
the
terms of the securities purchasable upon exercise of such warrants and the procedures and conditions relating to the exercise of such
warrants;
|
|
|
●
|
the
price at which the securities purchasable upon exercise of such warrants may be purchased;
|
|
|
●
|
the
date on which the right to exercise such warrants will commence and the date on which such right shall expire;
|
|
|
●
|
any
provisions for adjustment of the number or amount of securities receivable upon exercise of the warrants or the exercise price of the
warrants;
|
|
|
●
|
if
applicable, the minimum or maximum amount of such warrants that may be exercised at any one time;
|
|
|
●
|
if
applicable, the designation and terms of the securities with which such warrants are issued and the number of such warrants issued with
each such security;
|
|
|
●
|
if
applicable, the date on and after which such warrants and the related securities will be separately transferable;
|
|
|
●
|
information
with respect to book-entry procedures, if any;
|
|
|
●
|
the
terms of any rights to redeem or call the warrants;
|
|
|
●
|
United
States federal income tax consequences of holding or exercising the warrants, if material; and
|
|
|
●
|
any
other terms of such warrants, including terms, procedures and limitations relating to the exchange or exercise of such warrants.
|
Each warrant will entitle
its holder to purchase the number of ordinary shares or preferred shares of the relevant class or series at the exercise price set forth
in, or calculable as set forth in, the applicable prospectus supplement. The warrants may be exercised as set forth in the prospectus
supplement relating to the warrants offered. Unless we otherwise specify in the applicable prospectus supplement, warrants may be exercised
at any time up to the close of business on the expiration date set forth in the prospectus supplement relating to the warrants offered
thereby. After the close of business on the expiration date, unexercised warrants will become void.
We will specify the place
or places where, and the manner in which, warrants may be exercised in the form of warrant, warrant agreement or warrant certificate and
applicable prospectus supplement. Upon receipt of payment and the warrant or warrant certificate, as applicable, properly completed and
duly executed at the corporate trust office of the warrant agent, if any, or any other office, including ours, indicated in the prospectus
supplement, we will, as soon as practicable, issue and deliver the securities purchasable upon such exercise. If less than all of the
warrants (or the warrants represented by such warrant certificate) are exercised, a new warrant or a new warrant certificate, as applicable,
will be issued for the remaining amount of warrants. If we so indicate in the applicable prospectus supplement, holders of the warrants
may surrender securities as all or part of the exercise price for warrants.
Prior to the exercise of
any warrants to purchase ordinary shares or preferred shares of the relevant class or series, holders of the warrants will not have any
of the rights of holders of ordinary shares or preferred shares purchasable upon exercise, including the right to vote or to receive any
payments of dividends or payments upon our liquidation, dissolution or winding up on the ordinary shares or preferred shares purchasable
upon exercise, if any.
Outstanding Warrants
As of the date of this prospectus,
May 28, 2021, there were 18,411,196 outstanding warrants to purchase ordinary shares.
Description of Debt Securities
As used in this prospectus,
the term “debt securities” means the debentures, notes, bonds and other evidences of indebtedness that we may issue from time
to time. The debt securities will either be senior debt securities, senior subordinated debt or subordinated debt securities. We may also
issue convertible debt securities. Debt securities issued under an indenture (which we refer to herein as an Indenture) will be entered
into between us and a trustee to be named therein. It is likely that convertible debt securities will not be issued under an Indenture.
The Indenture or forms of
Indentures, if any, will be filed as exhibits to the registration statement of which this prospectus is a part.
As you read this section,
please remember that for each series of debt securities, the specific terms of your debt security as described in the applicable prospectus
supplement will supplement and, if applicable, may modify or replace the general terms described in the summary below. The statement we
make in this section may not apply to your debt security.
Events of Default Under the Indenture
Unless we provide otherwise
in the prospectus supplement or free writing prospectus applicable to a particular series of debt securities, the following are events
of default under the indentures with respect to any series of debt securities that we may issue:
|
|
●
|
if
we fail to pay the principal or premium, if any, when due and payable at maturity, upon redemption or repurchase or otherwise;
|
|
|
●
|
if
we fail to pay interest when due and payable and our failure continues for certain days;
|
|
|
●
|
if
we fail to observe or perform any other covenant contained in the Securities of a Series or in this Indenture, and our failure continues
for certain days after we receive written notice from the trustee or holders of at least certain percentage in aggregate principal amount
of the outstanding debt securities of the applicable series. The written notice must specify the Default, demand that it be remedied
and state that the notice is a “Notice of Default”;
|
|
|
●
|
if
specified events of bankruptcy, insolvency or reorganization occur; and
|
|
|
●
|
if
any other event of default provided with respect to securities of that series, which is specified in a Board Resolution, a supplemental
indenture hereto or an Officers’ Certificate as defined in the Form of Indenture.
|
We covenant in the Form of
Indenture to deliver a certificate to the trustee annually, within certain days after the close of the fiscal year, to show that we are
in compliance with the terms of the indenture and that we have not defaulted under the indenture.
Nonetheless, if we issue debt
securities, the terms of the debt securities and the final form of indenture will be provided in a prospectus supplement. Please refer
to the prospectus supplement and the form of indenture attached thereto for the terms and conditions of the offered debt securities. The
terms and conditions may or may not include whether or not we must furnish periodic evidence showing that an event of default does not
exist or that we are in compliance with the terms of the indenture.
The statements and descriptions
in this prospectus or in any prospectus supplement regarding provisions of the Indentures and debt securities are summaries thereof, do
not purport to be complete and are subject to, and are qualified in their entirety by reference to, all of the provisions of the Indentures
(and any amendments or supplements we may enter into from time to time which are permitted under each Indenture) and the debt securities,
including the definitions therein of certain terms.
General
Unless otherwise specified
in a prospectus supplement, the debt securities will be direct secured or unsecured obligations of our company. The senior debt securities
will rank equally with any of our other unsecured senior and unsubordinated debt. The subordinated debt securities will be subordinate
and junior in right of payment to any senior indebtedness.
We may issue debt securities
from time to time in one or more series, in each case with the same or various maturities, at par or at a discount. Unless indicated in
a prospectus supplement, we may issue additional debt securities of a particular series without the consent of the holders of the debt
securities of such series outstanding at the time of the issuance. Any such additional debt securities, together with all other outstanding
debt securities of that series, will constitute a single series of debt securities under the applicable Indenture and will be equal in
ranking.
Should an indenture relate
to unsecured indebtedness, in the event of a bankruptcy or other liquidation event involving a distribution of assets to satisfy our outstanding
indebtedness or an event of default under a loan agreement relating to secured indebtedness of our company or its subsidiaries, the holders
of such secured indebtedness, if any, would be entitled to receive payment of principal and interest prior to payments on the senior indebtedness
issued under an Indenture.
Prospectus Supplement
Each prospectus supplement
will describe the terms relating to the specific series of debt securities being offered. These terms will include some or all of the
following:
|
|
●
|
the
title of debt securities and whether they are subordinated, senior subordinated or senior debt securities;
|
|
|
●
|
any
limit on the aggregate principal amount of debt securities of such series;
|
|
|
●
|
the
percentage of the principal amount at which the debt securities of any series will be issued;
|
|
|
●
|
the
ability to issue additional debt securities of the same series;
|
|
|
●
|
the
purchase price for the debt securities and the denominations of the debt securities;
|
|
|
●
|
the
specific designation of the series of debt securities being offered;
|
|
|
●
|
the
maturity date or dates of the debt securities and the date or dates upon which the debt securities are payable and the rate or rates
at which the debt securities of the series shall bear interest, if any, which may be fixed or variable, or the method by which such rate
shall be determined;
|
|
|
●
|
the
basis for calculating interest if other than 360-day year or twelve 30-day months;
|
|
|
●
|
the
date or dates from which any interest will accrue or the method by which such date or dates will be determined;
|
|
|
●
|
the
duration of any deferral period, including the maximum consecutive period during which interest payment periods may be extended;
|
|
|
●
|
whether
the amount of payments of principal of (and premium, if any) or interest on the debt securities may be determined with reference to any
index, formula or other method, such as one or more currencies, commodities, equity indices or other indices, and the manner of determining
the amount of such payments;
|
|
|
●
|
the
dates on which we will pay interest on the debt securities and the regular record date for determining who is entitled to the interest
payable on any interest payment date;
|
|
|
●
|
the
place or places where the principal of (and premium, if any) and interest on the debt securities will be payable, where any securities
may be surrendered for registration of transfer, exchange or conversion, as applicable, and notices and demands may be delivered to or
upon us pursuant to the applicable Indenture;
|
|
|
●
|
the
rate or rates of amortization of the debt securities;
|
|
|
●
|
if
we possess the option to do so, the periods within which and the prices at which we may redeem the debt securities, in whole or in part,
pursuant to optional redemption provisions, and the other terms and conditions of any such provisions;
|
|
|
●
|
our
obligation or discretion, if any, to redeem, repay or purchase debt securities by making periodic payments to a sinking fund or through
an analogous provision or at the option of holders of the debt securities, and the period or periods within which and the price or prices
at which we will redeem, repay or purchase the debt securities, in whole or in part, pursuant to such obligation, and the other terms
and conditions of such obligation;
|
|
|
●
|
the
terms and conditions, if any, regarding the option or mandatory conversion or exchange of debt securities;
|
|
|
●
|
the
period or periods within which, the price or prices at which and the terms and conditions upon which any debt securities of the series
may be redeemed, in whole or in part at our option and, if other than by a board resolution, the manner in which any election by us to
redeem the debt securities shall be evidenced;
|
|
|
●
|
any
restriction or condition on the transferability of the debt securities of a particular series;
|
|
|
●
|
the
portion, or methods of determining the portion, of the principal amount of the debt securities which we must pay upon the acceleration
of the maturity of the debt securities in connection with any event of default if other than the full principal amount;
|
|
|
●
|
the
currency or currencies in which the debt securities will be denominated and in which principal, any premium and any interest will or
may be payable or a description of any units based on or relating to a currency or currencies in which the debt securities will be denominated;
|
|
|
●
|
provisions,
if any, granting special rights to holders of the debt securities upon the occurrence of specified events;
|
|
|
●
|
any
deletions from, modifications of or additions to the events of default or our covenants with respect to the applicable series of debt
securities, and whether or not such events of default or covenants are consistent with those contained in the applicable Indenture;
|
|
|
●
|
any
limitation on our ability to incur debt, redeem stock, sell our assets or other restrictions;
|
|
|
●
|
the
application, if any, of the terms of the applicable Indenture relating to defeasance and covenant defeasance (which terms are described
below) to the debt securities;
|
|
|
●
|
what
subordination provisions will apply to the debt securities;
|
|
|
●
|
the
terms, if any, upon which the holders may convert or exchange the debt securities into or for our Ordinary Shares, preferred shares or
other securities or property;
|
|
|
●
|
whether
we are issuing the debt securities in whole or in part in global form;
|
|
|
●
|
any
change in the right of the trustee or the requisite holders of debt securities to declare the principal amount thereof due and payable
because of an event of default;
|
|
|
●
|
the
depositary for global or certificated debt securities, if any;
|
|
|
●
|
any
material federal income tax consequences applicable to the debt securities, including any debt securities denominated and made payable,
as described in the prospectus supplements, in foreign currencies, or units based on or related to foreign currencies;
|
|
|
●
|
any
right we may have to satisfy, discharge and defease our obligations under the debt securities, or terminate or eliminate restrictive
covenants or events of default in the Indentures, by depositing money or U.S. government obligations with the trustee of the Indentures;
|
|
|
●
|
the
names of any trustees, depositories, authenticating or paying agents, transfer agents or registrars or other agents with respect to the
debt securities;
|
|
|
●
|
to
whom any interest on any debt security shall be payable, if other than the person in whose name the security is registered, on the record
date for such interest, the extent to which, or the manner in which, any interest payable on a temporary global debt security will be
paid if other than in the manner provided in the applicable Indenture;
|
|
|
●
|
if
the principal of or any premium or interest on any debt securities is to be payable in one or more currencies or currency units other
than as stated, the currency, currencies or currency units in which it shall be paid and the periods within and terms and conditions
upon which such election is to be made and the amounts payable (or the manner in which such amount shall be determined);
|
|
|
●
|
the
portion of the principal amount of any debt securities which shall be payable upon declaration of acceleration of the maturity of the
debt securities pursuant to the applicable Indenture if other than the entire principal amount;
|
|
|
●
|
if
the principal amount payable at the stated maturity of any debt security of the series will not be determinable as of any one or more
dates prior to the stated maturity, the amount which shall be deemed to be the principal amount of such debt securities as of any such
date for any purpose, including the principal amount thereof which shall be due and payable upon any maturity other than the stated maturity
or which shall be deemed to be outstanding as of any date prior to the stated maturity (or, in any such case, the manner in which such
amount deemed to be the principal amount shall be determined); and
|
|
|
●
|
any
other specific terms of the debt securities, including any modifications to the events of default under the debt securities and any other
terms which may be required by or advisable under applicable laws or regulations.
|
Unless otherwise specified
in the applicable prospectus supplement, the debt securities will not be listed on any securities exchange. Holders of the debt securities
may present registered debt securities for exchange or transfer in the manner described in the applicable prospectus supplement. Except
as limited by the applicable Indenture, we will provide these services without charge, other than any tax or other governmental charge
payable in connection with the exchange or transfer.
Debt securities may bear interest
at a fixed rate or a variable rate as specified in the prospectus supplement. In addition, if specified in the prospectus supplement,
we may sell debt securities bearing no interest or interest at a rate that at the time of issuance is below the prevailing market rate,
or at a discount below their stated principal amount. We will describe in the applicable prospectus supplement any special federal income
tax considerations applicable to these discounted debt securities.
We may issue debt securities
with the principal amount payable on any principal payment date, or the amount of interest payable on any interest payment date, to be
determined by referring to one or more currency exchange rates, commodity prices, equity indices or other factors. Holders of such debt
securities may receive a principal amount on any principal payment date, or interest payments on any interest payment date, that are greater
or less than the amount of principal or interest otherwise payable on such dates, depending upon the value on such dates of applicable
currency, commodity, equity index or other factors. The applicable prospectus supplement will contain information as to how we will determine
the amount of principal or interest payable on any date, as well as the currencies, commodities, equity indices or other factors to which
the amount payable on that date relates and certain additional tax considerations.
Description of Rights
We may issue rights to purchase
our securities. The rights may or may not be transferable by the persons purchasing or receiving the rights. In connection with any rights
offering, we may enter into a standby underwriting or other arrangement with one or more underwriters or other persons pursuant to which
such underwriters or other persons would purchase any offered securities remaining unsubscribed for after such rights offering. Each series
of rights will be issued under a separate rights agent agreement to be entered into between us and one or more banks, trust companies
or other financial institutions, as rights agent, that we will name in the applicable prospectus supplement. The rights agent will act
solely as our agent in connection with the rights and will not assume any obligation or relationship of agency or trust for or with any
holders of rights certificates or beneficial owners of rights.
The prospectus supplement
relating to any rights that we offer will include specific terms relating to the offering, including, among other matters:
|
|
●
|
the
date of determining the security holders entitled to the rights distribution;
|
|
|
●
|
the
aggregate number of rights issued and the aggregate amount of securities purchasable upon exercise of the rights;
|
|
|
●
|
the
conditions to completion of the rights offering;
|
|
|
●
|
the
date on which the right to exercise the rights will commence and the date on which the rights will expire; and
|
|
|
●
|
any
applicable federal income tax considerations.
|
Each right would entitle the
holder of the rights to purchase for cash the principal amount of securities at the exercise price set forth in the applicable prospectus
supplement. Rights may be exercised at any time up to the close of business on the expiration date for the rights provided in the applicable
prospectus supplement. After the close of business on the expiration date, all unexercised rights will become void.
If less than all of the rights
issued in any rights offering are exercised, we may offer any unsubscribed securities directly to persons other than our security holders,
to or through agents, underwriters or dealers or through a combination of such methods, including pursuant to standby arrangements, as
described in the applicable prospectus supplement.
Description of Units
The following description,
together with the additional information we may include in any applicable prospectus supplement, summarizes the material terms and provisions
of the units that we may offer under this prospectus. While the terms we have summarized below will apply generally to any units that
we may offer under this prospectus, we will describe the particular terms of any series of units in more detail in the applicable prospectus
supplement and any related free writing prospectus. The terms of any units offered under a prospectus supplement may differ from the terms
described below. However, no prospectus supplement will fundamentally change the terms that are set forth in this prospectus or offer
a security that is not registered and described in this prospectus at the time of its effectiveness.
We will file as an exhibit
to the registration statement of which this prospectus is a part, or will incorporate by reference from another report we file with the
SEC, the form of unit agreement that describes the terms of the series of units we may offer under this prospectus, and any supplemental
agreements, before the issuance of the related series of units. The following summaries of material terms and provisions of the units
are subject to, and qualified in their entirety by reference to, all the provisions of the unit agreement and any supplemental agreements
applicable to a particular series of units. We urge you to read the applicable prospectus supplement and any related free writing prospectus,
as well as the complete unit agreement and any supplemental agreements that contain the terms of the units.
We may issue units consisting
of any combination of the other types of securities offered under this prospectus in one or more series. We may evidence each series of
units by unit certificates that we may issue under a separate agreement. We may enter into unit agreements with a unit agent. Each unit
agent, if any, may be a bank or trust company that we select. We will indicate the name and address of the unit agent, if any, in the
applicable prospectus supplement relating to a particular series of units. Specific unit agreements, if any, will contain additional important
terms and provisions. We will file as an exhibit to the registration statement of which this prospectus is a part, or will incorporate
by reference from a current report that we file with the SEC, the form of unit and the form of each unit agreement, if any, relating to
units offered under this prospectus.
If we offer any units, certain
terms of that series of units will be described in the applicable prospectus supplement, including, without limitation, the following,
as applicable
|
|
●
|
the
title of the series of units;
|
|
|
●
|
identification
and description of the separate constituent securities comprising the units;
|
|
|
●
|
the
price or prices at which the units will be issued;
|
|
|
●
|
the
date, if any, on and after which the constituent securities comprising the units will be separately transferable;
|
|
|
●
|
a
discussion of certain United States federal income tax considerations applicable to the units; and
|
|
|
●
|
any
other material terms of the units and their constituent securities.
|
The provisions described in
this section, as well as those described under “Description of Share Capital - Ordinary Shares and Preferred Shares” and “Description
of Warrants” will apply to each unit and to any Ordinary Shares, preferred shares or warrant included in each unit, respectively.
Issuance in Series
We may issue units in such amounts and in numerous
distinct series as we determine.
Transfer Agent And Registrar
The transfer agent and registrar
for our ordinary shares is VStock Transfer, LLC, with a mailing address of 18 Lafayette Place Woodmere, NY 11598.
Nasdaq Capital Market Listing
Our Ordinary Shares are listed on the NASDAQ Capital
Market under the symbol “MYT.”
PLAN OF DISTRIBUTION
We may sell the securities
offered through this prospectus (i) to or through underwriters or dealers, (ii) directly to purchasers, including our affiliates, (iii)
through agents, or (iv) through a combination of any these methods. The securities may be distributed at a fixed price or prices, which
may be changed, market prices prevailing at the time of sale, prices related to the prevailing market prices, or negotiated prices. The
prospectus supplement will include the following information:
|
|
●
|
the
terms of the offering;
|
|
|
●
|
the
names of any underwriters or agents;
|
|
|
●
|
the
name or names of any managing underwriter or underwriters;
|
|
|
●
|
the
purchase price of the securities;
|
|
|
●
|
any
over-allotment options under which underwriters may purchase additional securities from us;
|
|
|
●
|
the
net proceeds from the sale of the securities;
|
|
|
●
|
any
delayed delivery arrangements;
|
|
|
●
|
any
underwriting discounts, commissions and other items constituting underwriters’ compensation;
|
|
|
●
|
any
initial public offering price;
|
|
|
●
|
any
discounts or concessions allowed or reallowed or paid to dealers;
|
|
|
●
|
any
commissions paid to agents; and
|
|
|
●
|
any
securities exchange or market on which the securities may be listed.
|
Sale Through Underwriters or Dealers
Only underwriters named in
the prospectus supplement are underwriters of the securities offered by the prospectus supplement. If underwriters are used in the sale,
the underwriters will acquire the securities for their own account, including through underwriting, purchase, security lending or repurchase
agreements with us. The underwriters may resell the securities from time to time in one or more transactions, including negotiated transactions.
Underwriters may sell the securities in order to facilitate transactions in any of our other securities (described in this prospectus
or otherwise), including other public or private transactions and short sales. Underwriters may offer securities to the public either
through underwriting syndicates represented by one or more managing underwriters or directly by one or more firms acting as underwriters.
Unless otherwise indicated in the prospectus supplement, the obligations of the underwriters to purchase the securities will be subject
to certain conditions, and the underwriters will be obligated to purchase all the offered securities if they purchase any of them. The
underwriters may change from time to time any public offering price and any discounts or concessions allowed or reallowed or paid to dealers.
If dealers are used in the
sale of securities offered through this prospectus, we will sell the securities to them as principals. They may then resell those securities
to the public at varying prices determined by the dealers at the time of resale. The prospectus supplement will include the names of the
dealers and the terms of the transaction.
We will provide in the applicable
prospectus supplement any compensation we will pay to underwriters, dealers or agents in connection with the offering of the securities,
and any discounts, concessions or commissions allowed by underwriters to participating dealers.
Direct Sales and Sales Through Agents
We may sell the securities
offered through this prospectus directly. In this case, no underwriters or agents would be involved. Such securities may also be sold
through agents designated from time to time. The prospectus supplement will name any agent involved in the offer or sale of the offered
securities and will describe any commissions payable to the agent. Unless otherwise indicated in the prospectus supplement, any agent
will agree to use its reasonable best efforts to solicit purchases for the period of its appointment.
We may sell the securities
directly to institutional investors or others who may be deemed to be underwriters within the meaning of the Securities Act with respect
to any sale of those securities. The terms of any such sales will be described in the prospectus supplement.
Delayed Delivery Contracts
If the prospectus supplement
indicates, we may authorize agents, underwriters or dealers to solicit offers from certain types of institutions to purchase securities
at the public offering price under delayed delivery contracts. These contracts would provide for payment and delivery on a specified date
in the future. The contracts would be subject only to those conditions described in the prospectus supplement. The applicable prospectus
supplement will describe the commission payable for solicitation of those contracts.
Market Making, Stabilization and Other Transactions
Unless the applicable prospectus
supplement states otherwise, other than our Ordinary Shares, all securities we offer under this prospectus will be a new issue and will
have no established trading market. We may elect to list offered securities on an exchange or in the over-the-counter market. Any underwriters
that we use in the sale of offered securities may make a market in such securities, but may discontinue such market making at any time
without notice. Therefore, we cannot assure you that the securities will have a liquid trading market.
Any underwriter may also engage
in stabilizing transactions, syndicate covering transactions and penalty bids in accordance with Rule 104 under the Securities Exchange
Act. Stabilizing transactions involve bids to purchase the underlying security in the open market for the purpose of pegging, fixing or
maintaining the price of the securities. Syndicate covering transactions involve purchases of the securities in the open market after
the distribution has been completed in order to cover syndicate short positions.
Penalty bids permit the underwriters
to reclaim a selling concession from a syndicate member when the securities originally sold by the syndicate member are purchased in a
syndicate covering transaction to cover syndicate short positions. Stabilizing transactions, syndicate covering transactions and penalty
bids may cause the price of the securities to be higher than it would be in the absence of the transactions. The underwriters may, if
they commence these transactions, discontinue them at any time.
General Information
Agents, underwriters, and
dealers may be entitled, under agreements entered into with us, to indemnification by us against certain liabilities, including liabilities
under the Securities Act. Our agents, underwriters, and dealers, or their affiliates, may be customers of, engage in transactions with
or perform services for us, in the ordinary course of business.
LEGAL MATTERS
Except as otherwise set forth
in the applicable prospectus supplement, certain legal matters in connection with the securities offered pursuant to this prospectus will
be passed upon for us by Hunter Taubman Fischer & Li LLC to the extent governed by the laws of the State of New York, and by Harney
Westwood & Riegels LP to the extent governed by the laws of the British Virgin Islands. If legal matters in connection with offerings
made pursuant to this prospectus are passed upon by counsel to underwriters, dealers or agents, such counsel will be named in the applicable
prospectus supplement relating to any such offering.
EXPERTS
The audited financial statements
incorporated in this prospectus by reference to the Annual Report on Form 20-F for the years ended June 30, 2020 and 2019 have been so
incorporated in reliance on the reports of Centurion ZD CPA & Co., the Company’s independent registered public accounting firm,
and its authority as experts in accounting and auditing, as set forth in their report thereon appearing elsewhere herein, and are included
in reliance upon such report given on the authority of such firm as experts in accounting and auditing.
FINANCIAL INFORMATION
The financial statements for
the year ended June 30, 2020 and 2019 are included in our Annual Report on Form 20-F, which are incorporated by reference into this prospectus.
INFORMATION INCORPORATED BY REFERENCE
The SEC allows us to “incorporate
by reference” into this prospectus the information we file with the SEC. This means that we can disclose important information to
you by referring you to those documents. Any statement contained in a document incorporated by reference in this prospectus shall be deemed
to be modified or superseded for purposes of this prospectus to the extent that a statement contained herein, or in any subsequently filed
document, which also is incorporated by reference herein, modifies or supersedes such earlier statement. Any such statement so modified
or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.
We hereby incorporate by reference
into this prospectus the following documents that we have filed with the SEC under the Exchange Act:
|
|
(1)
|
the
Company’s Annual Report on Form 20-F for the fiscal year ended June 30, 2020, filed with the SEC on October 30, 2021;
|
|
|
(2)
|
the
Company’s Current Reports, as amended on Form 6-K, filed with the SEC on July 20, 2020, July 27, 2020, August 18, 2020, November 17, 2020, February 19, 2021, March 22, 2021, March 26, 2021, March 29, 2021, April 20, 2021, April 27,2021, April 28, 2021, April 30,2021, and
May 5, 2021; and
|
|
|
(3)
|
the
description of our ordinary shares incorporated by reference in our registration statement on Form 8-A, as amended (File No. 001-35755)
filed with the SEC on June 1, 2015, including any amendment and report subsequently filed for the purpose of updating that description.
|
All documents that we file
with the SEC pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act (and in the case of a Current Report on Form 6-K, so long
as they state that they are incorporated by reference into this prospectus, and other
than Current Reports on Form 6-K, or portions thereof, furnished under Form 6-K) (i) after the initial filing date of the registration
statement of which this prospectus forms a part and prior to the effectiveness of such registration statement and (ii) after the date
of this prospectus and prior to the termination of the offering shall be deemed to be incorporated by reference in this prospectus from
the date of filing of the documents, unless we specifically provide otherwise. Information that we file with the SEC will automatically
update and may replace information previously filed with the SEC. To the extent that any information contained in any Current Report on
Form 6-K or any exhibit thereto, was or is furnished to, rather than filed with the SEC, such information or exhibit is specifically not
incorporated by reference.
Upon request, we will provide,
without charge, to each person who receives this prospectus, a copy of any or all of the documents incorporated by reference (other than
exhibits to the documents that are not specifically incorporated by reference in the documents). Please direct written or oral requests
for copies to us at Room 910, Building 1, Huitong Building, No.168, Hehua Road, Hehuayuan Street, Furong District, Changsha City, Hunan
Province, People’s Republic of China, Attention: Xianlong Wu, +86 0731-85133570.
WHERE YOU CAN FIND MORE INFORMATION
As permitted by SEC rules,
this prospectus omits certain information and exhibits that are included in the registration statement of which this prospectus forms
a part. Since this prospectus may not contain all of the information that you may find important, you should review the full text of these
documents. If we have filed a contract, agreement or other document as an exhibit to the registration statement of which this prospectus
forms a part, you should read the exhibit for a more complete understanding of the document or matter involved. Each statement in this
prospectus, including statements incorporated by reference as discussed above, regarding a contract, agreement or other document is qualified
in its entirety by reference to the actual document.
We are subject to the information
reporting requirements of the Exchange Act that are applicable to foreign private issuers, and, in accordance with these requirements,
we file annual and current reports and other information with the SEC. You may inspect, read (without charge) and copy the reports and
other information we file with the SEC at the SEC’s Public Reference Room located at 100 F Street, N.E., Washington, D.C. 20549.
You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also maintains
an internet website at www.sec.gov that contains our filed reports and other information that we file electronically
with the SEC.
We maintain a corporate website
at www.h-n-myt.com. Information contained on, or that can be accessed through, our website does not constitute a part of this prospectus.
ENFORCEABILITY OF CIVIL LIABILITIES
We are incorporated under
the laws of the British Virgin Islands (“BVI”) as a company with limited liability. We incorporated in the BVI because of
certain benefits associated with being a BVI corporation, such as political and economic stability, an effective judicial system, a favorable
tax system, the absence of foreign exchange control or currency restrictions and the availability of professional and support services.
However, BVI has a less developed body of securities laws that provide significantly less protection to investors as compared to the securities
laws of the United States. In addition, BVI companies may not have standing to sue before the federal courts of the United States.
All of our assets are located
in Hong Kong Special Administrative Region (“Hong Kong”), China, and the U.S. In addition, some of our directors and officers
are residents of jurisdictions other than the United States and all or a substantial portion of their assets are located outside the United
States. As a result, it may be difficult for investors to effect service of process within the United States upon us or our directors
and officers, or to enforce against us or them judgments obtained in United States courts, including judgments predicated upon the civil
liability provisions of the securities laws of the United States or any state in the United States.
According to our local BVI’s
counsel, there is uncertainty with regard to BVI law relating to whether a judgment obtained from the United States courts under civil
liability provisions of the securities laws will be determined by the courts of the BVI as penal or punitive in nature. If such a determination
is made, the courts of the BVI will not recognize or enforce the judgment against a BVI’s company. The courts of the BVI in the
past determined that disgorgement proceedings brought at the instance of the Securities and Exchange Commission are penal or punitive
in nature and such judgments would not be enforceable in the BVI. Other civil liability provisions of the securities laws may be characterized
as remedial, and therefore enforceable but the BVI’s Courts have not yet ruled in this regard. Our BVI’s counsel has further
advised us that a final and conclusive judgment in the federal or state courts of the United States under which a sum of money is payable
other than a sum payable in respect of taxes, fines, penalties or similar charges, may be subject to enforcement proceedings as a debt
in the courts of the BVI.
As of the date hereof, no
treaty or other form of reciprocity exists among the BVI, Hong Kong, and China governing the recognition and enforcement of judgments.
BVI counsel further advised
that although there is no statutory enforcement in the BVI of judgments obtained in the United States, Hong Kong, or China, a judgment
obtained in such jurisdictions will be recognized and enforced in the courts of the BVI at common law, without any re-examination of the
merits of the underlying dispute, by an action commenced on the foreign judgment debt in the courts of BVI, provided such judgment (1)
is given by a foreign court of competent jurisdiction, (2) imposes on the judgment debtor a liability to pay a liquidated sum for which
the judgment has been given, (3) is final, (4) is not in respect of taxes, a fine or a penalty, and (5) was not obtained in a manner and
is of a kind the enforcement of which is contrary to natural justice or the public policy of the BVI.
INDEMNIFICATION FOR SECURITIES ACT LIABILITIES
Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant
to the foregoing provisions, or otherwise, we have been informed that in the opinion of the SEC such indemnification is against public
policy as expressed in the Securities Act and is, therefore, unenforceable.
BIT BROTHER LIMITED
$200,000,000
Ordinary Shares,
Preferred Shares,
Debt Securities
Warrants,
Rights and
Units
PROSPECTUS
May 28, 2021
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 8. Indemnification of Directors and Officers
Our Memorandum and Articles
of Association, the BVI Business Companies Act, 2004, as amended, and the common law of the British Virgin Islands allow us to indemnify
our officers and directors from certain liabilities. Our Articles of Association provide that we may indemnify, hold harmless and exonerate
against all direct and indirect costs, fees and expenses of any type or nature whatsoever, any person who (a) is or was a party or is
threatened to be made a party to any proceeding by reason of the fact that such person is or was a director, officer, key employee, adviser
of the Company or who at the request of the Company; or (b) is or was, at the request of the Company, serving as a director of, or in
any other capacity is or was acting for, another company.
The Company will only
indemnify the individual in question if the relevant indemnitee acted honestly and in good faith with a view to the best interests of
the Company and, in the case of criminal proceedings, the indemnitee had no reasonable cause to believe that his conduct was unlawful.
The decision of the Board as to whether an indemnitee acted honestly and in good faith and with a view to the best interests of the Company
and as to whether such indemnitee had no reasonable cause to believe that his conduct was unlawful is, in the absence of fraud, sufficient
for the purposes of our Memorandum and Articles of Association, unless a question of law is involved.
The termination of any proceedings
by any judgment, order, settlement, conviction or the entering of a nolle prosequi does not, by itself, create a presumption that the
relevant indemnitee did not act honestly and in good faith and with a view to the best interests of the Company or that such indemnitee
had reasonable cause to believe that his conduct was unlawful.
The Company may purchase
and maintain insurance, purchase or furnish similar protection or make other arrangements including, but not limited to, providing a trust
fund, letter of credit, or surety bond in relation to any indemnitee or who at the request of the Company is or was serving as a director,
officer or liquidator of, or in any other capacity is or was acting for, another company, against any liability asserted against the person
and incurred by him in that capacity, whether or not the Company has or would have had the power to indemnify him against the liability
as provided in our Memorandum and Articles of Association.
Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling
us under the foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against public policy
as expressed in the Securities Act and is therefore unenforceable.
Item 9. Exhibits
|
|
**
|
To
be filed by amendment or as an exhibit to a filing with the SEC under Section 13 or 15(d) of the Securities Exchange Act of 1934 and
incorporated by reference in connection with the offering of securities to the extent required for any such offering.
|
Item 10 Undertakings
|
|
(a)
|
The
undersigned registrant hereby undertakes:
|
|
|
(1)
|
To
file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
|
|
|
(i)
|
To
include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;
|
|
|
(ii)
|
To
reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume
and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration
Fee” table in the effective registration statement.
|
|
|
(iii)
|
To
include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any
material change to such information in the registration statement.
|
provided, however, that paragraphs
(a)(1)(i), (a)(1)(ii) and (a)(1)(iii) of this section do not apply if the information required to be included in a post-effective amendment
by those paragraphs is contained in reports filed with or furnished to the Securities and Exchange Commission by the registrant pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is
contained in a form of prospectus filed pursuant to Rule 424(b).
|
|
(2)
|
That,
for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to
be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be
deemed to be the initial bona fide offering thereof.
|
|
|
(3)
|
To
remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination
of the offering.
|
|
|
(4)
|
That,
for the purpose of determining liability under the Securities Act of 1933 to any purchaser:
|
|
|
(i)
|
Each
prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date
the filed prospectus was deemed part of and included in the registration statement; and
|
|
|
(ii)
|
Each
prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule
430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required
by Section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier
of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the
offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date
an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the
registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus
that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration
statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such
effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration
statement or made in any such document immediately prior to such effective date.
|
|
|
(5)
|
That,
for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution
of the securities: The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant
to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities
are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to
the purchaser and will be considered to offer or sell such securities to such purchaser:
|
|
|
(i)
|
Any
preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;
|
|
|
(ii)
|
Any
free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the
undersigned registrant;
|
|
|
(iii)
|
The
portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
or its securities provided by or on behalf of the undersigned registrant; and
|
|
|
(iv)
|
Any
other communication that is an offer in the offering made by the undersigned registrant to the purchaser.
|
|
|
(b)
|
That,
for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant
to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s
annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration
statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.
|
|
|
(c)
|
Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons
of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities
and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the
event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid
by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted
by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the
opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question
whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of
such issue.
|
SIGNATURES
Pursuant to the requirements
of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form F-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the People’s Republic of China, on May 28, 2021.
|
|
BIT BROTHER LIMITED
|
|
|
|
|
|
By:
|
/s/ Xianlong Wu
|
|
|
|
Name:
|
Xianlong Wu
|
|
|
|
Title:
|
Chief Executive Officer
|
POWER OF ATTORNEY
Each person whose signature
appears below hereby constitutes and appoints Xianlong Wu and Diyu Jiang, and each of them, individually, his or her true and lawful attorneys-in-fact
and agents, with full power of substitution and resubstitution, in his or her name, place and stead, in any and all capacities (including
his capacity as a director and/or officer of the registrant), to sign any and all amendments and post-effective amendments and supplements
to this registration statement, and including any registration statement for the same offering that is to be effective upon filing pursuant
to Rule 462(b) under the U.S. Securities Act of 1933, as amended, and to file the same, with all exhibits thereto and other documents
in connection therewith, with the SEC, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to
do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and
purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them,
or his substitute, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements
of the U.S. Securities Act of 1933, as amended, this Form F-3 registration statement has been signed by the following persons in the capacities
and on the date indicated.
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ Xianlong Wu
|
|
Chief Executive Officer and
Chairman of the Board of Directors
|
|
May 28, 2021
|
|
Xianlong Wu
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
|
|
/s/ Diyu Jiang
|
|
Chief Financial Officer and Director
|
|
May 28, 2021
|
|
Diyu Jiang
|
|
(Principal Accounting and Financial Officer)
|
|
|
|
|
|
|
|
|
|
/s/ Shu Liu
|
|
Chief Operation Officer
|
|
May 28, 2021
|
|
Shu Liu
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Jing Yi
|
|
Independent Director
|
|
May 28, 2021
|
|
Jing Yi
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Anatoly Danilitskiy
|
|
Independent Director
|
|
May 28, 2021
|
|
Anatoly Danilitskiy
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Yunfei Song
|
|
Independent Director
|
|
May 28, 2021
|
|
Yunfei Song
|
|
|
|
|
SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES
Pursuant to the Securities
Act of 1933, the undersigned, the duly authorized representative in the United States of the Company has signed this Registration Statement
or amendment thereto in Newark, Delaware on May 28, 2021.
|
|
Authorized U.S. Representative
|
|
|
|
|
|
By:
|
/s/
Donald J. Puglisi
|
|
|
Name:
|
Donald J. Puglisi
|
|
|
Title:
|
Managing Director
|
II-4
Urban Tea (NASDAQ:MYT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Urban Tea (NASDAQ:MYT)
Historical Stock Chart
From Apr 2023 to Apr 2024
